Mark H Chan, MD
Physical Medicine and Rehabilitation · Oakland
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 33 years
- Graduated 1993
On the public record
- Owns East Bay Special Surgery, LLC: Accreditation Lapsed
Offices
1 location
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G84716 · Current
Licensed to practise in California · since 1998 · expires 2027-10-31 · University of Hawaii School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- East Bay Special Surgery, LLCAmbulatory Surgery Center · Oakland, CA4% owner since 2009 · accredited by AAAHCAccreditation Lapsed2 inspections, 1 with deficiencies · last 2013-06-21: Requirements Met
- East Bay Special Surgery, LLCAmbulatory Surgery Center · Oakland, CA3.83% owner since 2006 · accredited by IMQAccreditation Lapsed1 inspection, 1 with deficiencies · last 2015-11-19: Requirements Met
- Webster Surgery Center, LPAmbulatory Surgery Center · Oakland, CAOwner · accredited by AAAHCAccreditation Lapsed2 inspections · last 2015-07-27
- Surgery Center of Oakland, LP dba The Surgery Center of OaklandAmbulatory Surgery Center · Oakland, CA5.86% owner since 2023 · accredited by AAAHCAccreditation Renewed5 inspections, 4 with deficiencies · last 2024-03-27
- The Surgery Center of Alta Bates Summit Medical CenterAmbulatory Surgery Center · Oakland, CAOwner · accredited by JCInitial Accreditation4 inspections, 4 with deficiencies · last 2017-07-27: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Physical Medicine and Rehabilitation - Pain Medicine
- American Board of Physical Medicine and Rehabilitation - Physical Medicine and Rehabilitation
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$83,209
Medicare paid this office $83,209 for 212 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 170 | $47,487 | $122 |
| New patient visit (45+ min) | 75 | $11,775 | $157 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 49 | $7,673 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $2,854 | $95 |
| Nerve test | 13 | $2,720 | $209 |
See all 8 services
| Return visit (30+ min) | 170 | $47,487 | $122 |
| New patient visit (45+ min) | 75 | $11,775 | $157 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 49 | $7,673 | $115 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 23 | $2,854 | $95 |
| Nerve test | 13 | $2,720 | $209 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 29 | $1,677 | $45 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 21 | $1,337 | $50 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 14 | $1,089 | $78 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 86 | 39 | 64 | 78 | 52 | 67 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 45 | 27 | 38 | 56 | 29 | 37 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 38 | 16 | 32 | 36 | 23 | 30 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 38 | 16 | 32 | 34 | 21 | 27 |
| Injection of substance into spinal canal for removal of lower spine nerve tissue | 28 | – | – | – | – | – |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | – | – | – | – | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
212 Original Medicare patients in 2024. Average age 76 · Women 57% · Health risk score 1.06. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 66% · Depression 23% · Cancer 21% · Coronary heart disease 20% · Chronic kidney disease 20% · Diabetes 19% · Atrial fibrillation 16% · Heart failure 9% · COPD 8%.
The office billed $212,795, Medicare allowed $104,435 and paid $83,209; for 724 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 212 | 724 | 76 | 1.06 | $212,795 | $83,209 |
| 2023 | 215 | 623 | 75 | 0.90 | $179,915 | $68,644 |
| 2022 | 233 | 851 | 76 | 0.86 | $240,645 | $93,645 |
| 2021 | 200 | 721 | 75 | 0.84 | $192,425 | $82,030 |
| 2020 | 146 | 391 | 75 | 1.07 | $106,285 | $38,536 |
| 2019 | 236 | 764 | 74 | 0.94 | $205,100 | $77,365 |
| 2018 | 302 | 973 | 74 | 0.98 | $238,025 | $98,168 |
| 2017 | 341 | 1,074 | 74 | 0.95 | $277,725 | $107,139 |
| 2016 | 338 | 1,221 | 74 | 0.91 | $315,940 | $118,889 |
| 2015 | 339 | 1,131 | 74 | 1.01 | $273,910 | $107,737 |
| 2014 | 320 | 1,123 | 74 | 0.88 | $257,905 | $107,675 |
| 2013 | 303 | 1,061 | 74 | 0.99 | $241,720 | $99,032 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 170 | $37,174 | $117 |
| New patient visit (45+ min) | 68 | $10,354 | $152 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 45 | $5,791 | $111 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $2,119 | $92 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,313 | $45 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 20 | $1,045 | $50 |
| Injection, methylprednisolone acetate, 20 mg | 16 | $74 | None |
2022: 8 services
| Return visit (30+ min) | 191 | $51,833 | $118 |
| New patient visit (45+ min) | 84 | $12,979 | $155 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 65 | $8,838 | $113 |
| Nerve test | 16 | $3,827 | $213 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 33 | $3,309 | $92 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 48 | $2,558 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 31 | $1,718 | $51 |
| Injection, methylprednisolone acetate, 20 mg | 17 | $50 | None |
2021: 7 services
| Return visit (30+ min) | 162 | $44,526 | $121 |
| New patient visit (45+ min) | 76 | $11,915 | $157 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 51 | $7,524 | $118 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 28 | $2,968 | $93 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 29 | $1,783 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 28 | $1,653 | $52 |
| Injection, methylprednisolone acetate, 20 mg | 13 | $43 | None |
2020: 7 services
| Return visit (30+ min) | 115 | $19,106 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 30 | $4,374 | $112 |
| New patient visit (45+ min) | 29 | $3,826 | $132 |
| Nerve test | 12 | $2,523 | $210 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,485 | $93 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 21 | $1,259 | $47 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 16 | $836 | $52 |
2019: 9 services
| Return visit (30+ min) | 189 | $35,635 | $101 |
| New patient visit (45+ min) | 80 | $11,684 | $146 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 70 | $9,400 | $109 |
| Injection of substance into spinal canal for removal of lower spine nerve tissue | 22 | $3,735 | $133 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 36 | $3,549 | $93 |
| Nerve test | 15 | $3,403 | $227 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 40 | $2,057 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 36 | $1,996 | $53 |
| Injection, methylprednisolone acetate, 20 mg | 14 | $54 | None |
2018: 10 services
| Return visit (30+ min) | 228 | $45,410 | $99 |
| New patient visit (45+ min) | 127 | $18,713 | $147 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 82 | $12,043 | $115 |
| Injection of substance into spinal canal for removal of lower spine nerve tissue | 31 | $4,651 | $133 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 39 | $4,160 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 38 | $2,249 | $55 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 12 | $2,162 | $120 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 37 | $1,819 | $47 |
| Aspiration and/or injection of fluid from large joint | 20 | $1,099 | $52 |
| Injection, methylprednisolone acetate, 20 mg | 28 | $127 | None |
2017: 13 services
| Return visit (30+ min) | 255 | $46,170 | $96 |
| New patient visit (45+ min) | 139 | $20,218 | $145 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 93 | $15,426 | $114 |
| Injection of substance into spinal canal for removal of lower spine nerve tissue | 37 | $5,399 | $132 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 39 | $3,846 | $94 |
| Nerve test | 15 | $3,350 | $223 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 46 | $2,528 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 38 | $2,126 | $53 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 15 | $2,016 | $119 |
| Nerve test | 14 | $1,947 | $139 |
| Injection of trigger points, 1-2 muscles | 12 | $1,025 | $51 |
| Aspiration and/or injection of fluid from large joint | 17 | $984 | $55 |
| Injection, methylprednisolone acetate, 20 mg | 29 | $153 | None |
2016: 12 services
| Return visit (30+ min) | 267 | $54,390 | $95 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 113 | $19,591 | $115 |
| New patient visit (45+ min) | 132 | $19,014 | $144 |
| Nerve test | 18 | $3,878 | $215 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 42 | $3,702 | $82 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 20 | $3,171 | $117 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 50 | $2,877 | $46 |
| Injection of substance into spinal canal for removal of lower spine nerve tissue | 19 | $2,830 | $129 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 40 | $2,022 | $47 |
| Nerve test | 14 | $1,842 | $132 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,354 | $52 |
| Injection, methylprednisolone acetate, 20 mg | 31 | $133 | None |
2015: 11 services
| Return visit (30+ min) | 264 | $49,581 | $94 |
| New patient visit (45+ min) | 140 | $20,120 | $144 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 98 | $13,518 | $106 |
| Removal of spinal canal scar tissue, multiple sessions in 1 day | 18 | $4,172 | $209 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 39 | $3,630 | $82 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 55 | $2,917 | $46 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 14 | $2,239 | $118 |
| Nerve test | 15 | $2,062 | $137 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 38 | $1,959 | $47 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,234 | $54 |
| Injection, methylprednisolone acetate, 20 mg | 35 | $102 | None |
2014: 9 services
| Return visit (30+ min) | 263 | $54,433 | $94 |
| New patient visit (45+ min) | 130 | $18,667 | $144 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 85 | $11,310 | $101 |
| Removal of spinal canal scar tissue, multiple sessions in 1 day | 32 | $7,160 | $211 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 44 | $4,345 | $82 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 44 | $2,422 | $46 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 40 | $2,394 | $46 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,065 | $53 |
| Injection, methylprednisolone acetate, 20 mg | 26 | $94 | None |
2013: 11 services
| Return visit (30+ min) | 238 | $47,279 | $93 |
| New patient visit (45+ min) | 130 | $17,910 | $138 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 72 | $9,492 | $100 |
| Removal of spinal canal scar tissue, multiple sessions in 1 day | 36 | $7,970 | $204 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 26 | $3,029 | $82 |
| Nerve test | 14 | $2,666 | $190 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 41 | $2,133 | $45 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 26 | $1,665 | $45 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,392 | $52 |
| Injection of trigger points, 1-2 muscles | 14 | $1,308 | $50 |
| Injection, methylprednisolone acetate, 20 mg | 39 | $135 | None |
Drugs they prescribed that Part D paid
$8,607
Pharmacies billed $8,607 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 49% of their Part D prescriptions (281 of 572) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 6% of their opioid prescriptions.
572 generic and 0 brand-name prescriptions · $8,607 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 151 | $2,383 | $16 |
| Hydrocodone-Acetaminophen | 127 | $1,197 | $9 |
| Fentanyl | 12 | $1,071 | $89 |
| Pregabalin | 32 | $939 | $29 |
| Oxycodone-Acetaminophen | 40 | $552 | $14 |
See all 11 drugs
| Gabapentin | 151 | $2,383 | $16 |
| Hydrocodone-Acetaminophen | 127 | $1,197 | $9 |
| Fentanyl | 12 | $1,071 | $89 |
| Pregabalin | 32 | $939 | $29 |
| Oxycodone-Acetaminophen | 40 | $552 | $14 |
| Tramadol | 62 | $332 | $5 |
| Baclofen | 16 | $286 | $18 |
| Cyclobenzaprine | 18 | $213 | $12 |
| Oxycodone | 22 | $198 | $9 |
| Meloxicam | 34 | $137 | $4 |
| Tramadol Hcl-Acetaminophen | 14 | $62 | $4 |
Year by year
| 2024 | 572 | 108 | 49% (281) | 0% | $8,607 |
| 2023 | 700 | 118 | 45% (314) | 0% | $12,226 |
| 2022 | 775 | 139 | 44% (342) | None | $14,996 |
| 2021 | 824 | 132 | 49% (405) | 2% | $18,508 |
| 2020 | 817 | 131 | 48% (391) | 2% | $20,848 |
| 2019 | 892 | 164 | 42% (377) | 7% | $42,542 |
| 2018 | 934 | 194 | 39% (362) | 7% | $54,794 |
| 2017 | 944 | 172 | 41% (389) | 5% | $45,056 |
| 2016 | 1,130 | 190 | 42% (474) | 8% | $64,131 |
| 2015 | 1,062 | 180 | 41% (437) | 15% | $72,476 |
| 2014 | 1,067 | 186 | 46% (492) | 13% | $61,553 |
| 2013 | 942 | 168 | 47% (443) | 16% | $56,893 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Gabapentin | 185 | $2,816 | $15 |
| Hydrocodone-Acetaminophen | 174 | $2,472 | $14 |
| Fentanyl | 12 | $1,954 | $163 |
| Pregabalin | 24 | $1,394 | $58 |
| Baclofen | 27 | $408 | $15 |
| Oxycodone-Acetaminophen | 27 | $332 | $12 |
| Meloxicam | 48 | $325 | $7 |
| Cyclobenzaprine | 24 | $275 | $11 |
| Oxycodone | 19 | $266 | $14 |
| Tramadol | 56 | $240 | $4 |
| Duloxetine | 11 | $226 | $21 |
| Diazepam | 11 | $101 | $9 |
| Carisoprodol | 11 | $45 | $4 |
| Methocarbamol | 11 | $36 | $3 |
| Tramadol Hcl-Acetaminophen | 12 | $20 | $2 |
2022: 15 drugs
| Hydrocodone-Acetaminophen | 220 | $3,420 | $16 |
| Gabapentin | 188 | $2,458 | $13 |
| Pregabalin | 47 | $2,296 | $49 |
| Fentanyl | 12 | $1,954 | $163 |
| Celecoxib | 16 | $1,058 | $66 |
| Tramadol Hcl Er | 11 | $942 | $86 |
| Duloxetine | 16 | $414 | $26 |
| Baclofen | 37 | $356 | $10 |
| Oxycodone | 18 | $191 | $11 |
| Tramadol | 49 | $159 | $3 |
| Meloxicam | 48 | $151 | $3 |
| Tizanidine | 21 | $133 | $6 |
| Diazepam | 11 | $82 | $7 |
| Carisoprodol | 24 | $70 | $3 |
| Tramadol Hcl-Acetaminophen | 12 | $28 | $2 |
2021: 18 drugs
| Butrans | 12 | $4,110 | $342 |
| Hydrocodone-Acetaminophen | 225 | $4,000 | $18 |
| Gabapentin | 221 | $3,213 | $15 |
| Fentanyl | 12 | $1,892 | $158 |
| Celecoxib | 12 | $945 | $79 |
| Pregabalin | 22 | $822 | $37 |
| Baclofen | 47 | $494 | $11 |
| Morphine Sulfate Er | 21 | $443 | $21 |
| Tizanidine | 15 | $435 | $29 |
| Duloxetine | 22 | $434 | $20 |
| Tramadol | 80 | $337 | $4 |
| Oxycodone-Acetaminophen | 17 | $309 | $18 |
| Oxycodone | 19 | $184 | $10 |
| Tramadol Hcl-Acetaminophen | 12 | $83 | $7 |
| Carisoprodol | 25 | $83 | $3 |
| Diazepam | 12 | $66 | $6 |
| Meloxicam | 19 | $51 | $3 |
| Cyclobenzaprine | 13 | $38 | $3 |
2020: 14 drugs
| Butrans | 15 | $4,765 | $318 |
| Gabapentin | 236 | $3,232 | $14 |
| Hydrocodone-Acetaminophen | 203 | $2,733 | $13 |
| Pregabalin | 27 | $1,410 | $52 |
| Morphine Sulfate Er | 27 | $500 | $19 |
| Baclofen | 40 | $408 | $10 |
| Tramadol | 82 | $341 | $4 |
| Tizanidine | 16 | $305 | $19 |
| Duloxetine | 15 | $283 | $19 |
| Oxycodone | 22 | $281 | $13 |
| Meloxicam | 39 | $181 | $5 |
| Diazepam | 15 | $105 | $7 |
| Cyclobenzaprine | 13 | $49 | $4 |
| Tramadol Hcl-Acetaminophen | 13 | $26 | $2 |
2019: 17 drugs
| Lyrica | 25 | $11,768 | $471 |
| Butrans | 35 | $11,627 | $332 |
| Buprenorphine | 12 | $6,251 | $521 |
| Gabapentin | 237 | $4,340 | $18 |
| Hydrocodone-Acetaminophen | 171 | $2,346 | $14 |
| Pregabalin | 12 | $973 | $81 |
| Tramadol | 78 | $697 | $9 |
| Tizanidine | 27 | $526 | $19 |
| Meloxicam | 85 | $372 | $4 |
| Morphine Sulfate Er | 22 | $369 | $17 |
| Oxycodone-Acetaminophen | 21 | $350 | $17 |
| Baclofen | 49 | $275 | $6 |
| Oxycodone | 20 | $234 | $12 |
| Diazepam | 15 | $81 | $5 |
| Cyclobenzaprine | 16 | $66 | $4 |
| Tramadol Hcl-Acetaminophen | 12 | $22 | $2 |
| Carisoprodol | 11 | $16 | $1 |
2018: 15 drugs
| Butrans | 39 | $21,750 | $558 |
| Lyrica | 22 | $9,351 | $425 |
| Gabapentin | 258 | $4,108 | $16 |
| Hydrocodone-Acetaminophen | 184 | $2,535 | $14 |
| Celecoxib | 11 | $2,103 | $191 |
| Norco | 12 | $1,957 | $163 |
| Tizanidine | 60 | $823 | $14 |
| Oxycodone-Acetaminophen | 23 | $718 | $31 |
| Tramadol | 52 | $592 | $11 |
| Duloxetine | 16 | $590 | $37 |
| Morphine Sulfate Er | 20 | $548 | $27 |
| Meloxicam | 129 | $422 | $3 |
| Baclofen | 30 | $171 | $6 |
| Tramadol Hcl-Acetaminophen | 13 | $22 | $2 |
| Carisoprodol | 13 | $18 | $1 |
2017: 19 drugs
| Butrans | 28 | $16,112 | $575 |
| Lyrica | 14 | $8,359 | $597 |
| Gabapentin | 292 | $3,976 | $14 |
| Norco | 21 | $3,099 | $148 |
| Celecoxib | 19 | $1,858 | $98 |
| Hydrocodone-Acetaminophen | 147 | $1,824 | $12 |
| Fentanyl | 23 | $1,144 | $50 |
| Morphine Sulfate Er | 32 | $1,010 | $32 |
| Duloxetine | 20 | $763 | $38 |
| Tizanidine | 67 | $677 | $10 |
| Tramadol | 82 | $646 | $8 |
| Oxycodone-Acetaminophen | 20 | $375 | $19 |
| Meloxicam | 60 | $242 | $4 |
| Oxycodone | 15 | $94 | $6 |
| Cyclobenzaprine | 15 | $91 | $6 |
| Naproxen | 11 | $56 | $5 |
| Diazepam | 12 | $23 | $2 |
| Tramadol Hcl-Acetaminophen | 12 | $19 | $2 |
| Carisoprodol | 12 | $16 | $1 |
2016: 19 drugs
| Butrans | 33 | $19,870 | $602 |
| Lyrica | 25 | $10,210 | $408 |
| Oxycontin | 19 | $7,026 | $370 |
| Fentanyl | 80 | $5,951 | $74 |
| Gabapentin | 326 | $4,692 | $14 |
| Hydrocodone-Acetaminophen | 168 | $3,210 | $19 |
| Duloxetine | 56 | $2,764 | $49 |
| Norco | 21 | $2,726 | $130 |
| Celecoxib | 21 | $2,509 | $119 |
| Tramadol | 99 | $861 | $9 |
| Oxycodone-Acetaminophen | 35 | $660 | $19 |
| Tizanidine | 48 | $500 | $10 |
| Morphine Sulfate Er | 22 | $383 | $17 |
| Baclofen | 21 | $141 | $7 |
| Meloxicam | 29 | $140 | $5 |
| Tramadol Hcl-Acetaminophen | 12 | $125 | $10 |
| Cyclobenzaprine | 30 | $92 | $3 |
| Diazepam | 12 | $39 | $3 |
| Carisoprodol | 13 | $39 | $3 |
2015: 15 drugs
| Butrans | 52 | $21,137 | $406 |
| Lyrica | 27 | $10,976 | $407 |
| Oxycontin | 33 | $9,602 | $291 |
| Gabapentin | 330 | $5,430 | $16 |
| Fentanyl | 57 | $4,648 | $82 |
| Celecoxib | 22 | $3,989 | $181 |
| Duloxetine | 64 | $3,636 | $57 |
| Hydrocodone-Acetaminophen | 160 | $2,155 | $13 |
| Norco | 12 | $1,472 | $123 |
| Morphine Sulfate Er | 24 | $964 | $40 |
| Tramadol | 106 | $779 | $7 |
| Voltaren | 14 | $650 | $46 |
| Oxycodone-Acetaminophen | 20 | $445 | $22 |
| Cyclobenzaprine | 22 | $74 | $3 |
| Meloxicam | 14 | $52 | $4 |
2014: 15 drugs
| Butrans | 38 | $10,772 | $283 |
| Lyrica | 46 | $9,814 | $213 |
| Oxycontin | 24 | $7,318 | $305 |
| Lidocaine | 32 | $6,873 | $215 |
| Gabapentin | 340 | $5,230 | $15 |
| Fentanyl | 43 | $4,293 | $100 |
| Duloxetine | 23 | $2,564 | $111 |
| Hydrocodone-Acetaminophen | 245 | $2,536 | $10 |
| Norco | 13 | $1,500 | $115 |
| Morphine Sulfate Er | 23 | $749 | $33 |
| Tramadol | 90 | $640 | $7 |
| Oxycodone-Acetaminophen | 16 | $514 | $32 |
| Voltaren | 11 | $486 | $44 |
| Nabumetone | 11 | $174 | $16 |
| Tramadol Hcl-Acetaminophen | 13 | $164 | $13 |
2013: 13 drugs
| Lidoderm | 31 | $11,833 | $382 |
| Butrans | 26 | $8,328 | $320 |
| Lyrica | 25 | $6,640 | $266 |
| Gabapentin | 294 | $5,802 | $20 |
| Oxycontin | 16 | $5,023 | $314 |
| Celebrex | 14 | $3,960 | $283 |
| Fentanyl | 34 | $3,677 | $108 |
| Hydrocodone-Acetaminophen | 222 | $2,282 | $10 |
| Voltaren | 19 | $1,001 | $53 |
| Tramadol | 102 | $872 | $9 |
| Morphine Sulfate Er | 25 | $578 | $23 |
| Orphenadrine Citrate | 12 | $508 | $42 |
| Cyclobenzaprine | 24 | $184 | $8 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871532945
- Licence
- CA G84716California G84716: Current · expires 2027-10-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- 80 Grand Ave, Suite 610, Oakland, CA, 94612
- NPI first listed
- 2006-06-05
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.